MMCAP International’s Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 LHC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-36,032
Closed -$23K 544
2021
Q3
$23K Sell
36,032
-8,425
-19% -$6.55K ﹤0.01% 411
2021
Q2
$43 Hold
44,457
﹤0.01% 389
2021
Q1
$33K Buy
+44,457
New +$44.6K ﹤0.01% 315

Other funds holding LHC.WS

MMCAP International's LHC.WS Position: Q4 2021 in Review

MMCAP International sold out of Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (LHC.WS) in Q4 2021, closing a stake of 36,032 shares — an estimated $23K sold.

MMCAP International first reported a position in LHC.WS in Q1 2021 and held it in 3 quarters. The position peaked at $33K in Q1 2021. 50 funds tracked by Wall St. Rank hold LHC.WS as of Q4 2021.

  • MMCAP International reported no remaining Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2021 after selling out during the quarter.
  • MMCAP International sold 36,032 Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2021, an estimated $23K.
  • MMCAP International first reported a position in Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2021 and held it in 3 quarters.
  • MMCAP International's Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $33K in Q1 2021.
  • 50 funds tracked by Wall St. Rank held Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2021.

Based on MMCAP International's 13F filing for Q4 2021, filed 9 Feb 2022.